Study Comparing 3 Dosage Levels Of SAM-531 In Outpatients With Mild To Moderate Alzheimer Disease
Clinical trial NCT00895895 · TERMINATED
Trial details
- NCT number
- NCT00895895
- Sponsor
- Pfizer
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-05-01
- Primary completion
- 2011-05-01
- Enrollment
- 526
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.